Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
about
The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic ReviewGuidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyCost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.Does age or bilateral disease influence the value of hip arthroplasty?Outcomes of coronary artery bypass graft surgery.Health-Related Quality of Life among Patients with Coronary Artery Disease: A Post-Treatment Follow-Up Study in Iran.Role of surgical revascularization in diabetic patients with coronary artery disease.Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers.A propensity matched comparison of return to work and quality of life after stenting or coronary artery bypass surgery.Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study.Cost-effectiveness as an outcome in randomized clinical trials.Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.Effect of race on the clinical outcomes in the bypass angioplasty revascularization investigation trialMultivessel coronary artery disease: quantifying how recent trials should influence clinical practice.Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.Medical expenditures in patients with high risk of diabetes: Effects of BMI, hypertension, and health-related quality of life.Angina and associated healthcare costs following percutaneous coronary intervention: A real-world analysis from a multi-payer database.Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario.Predictors of Quality of Life Improvement after 2 Years of Coronary Artery Bypass Surgery.Angina and Its Management.Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.Utility and quality-adjusted life-years in coronary artery disease: Five-year follow-up of the MASS II trial.Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease.Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions.
P2860
Q28074140-20F756B4-0861-434E-994A-7A83AE2B91F8Q28239975-AB1084E9-4A05-4B39-AB44-82B67CCAC7F1Q35698518-9D46E123-F7D9-4645-811C-0D1F973DAFD8Q35802851-A1518656-47D9-45F3-9CB0-FF8822DC9CC1Q36013074-F2BB43B0-1456-4B27-A608-8083405EDAE9Q36036530-DB862FF4-6533-4D03-824F-05641103B313Q36107202-D2A8E3D0-77A8-4E7D-A243-1191F4A26B0CQ36112385-04F0CC17-B4C9-4BB4-90A5-B09245B95A24Q36295307-897E9C47-3224-4C38-A922-02363D983AB3Q36472697-3E83C56F-BA3D-4599-9311-38CA1A7808A4Q36536868-A48FE5E3-CA2E-4195-B093-6D918EDB9340Q36684587-85260061-053D-4AB3-81E8-CAD749DBAB3CQ36703074-EFA568B1-6945-48FA-B1DE-6924D54238EDQ37439864-022E1D9C-F13A-4F0C-845D-C2F9F461D922Q38124877-F078EDB6-8CCC-4F70-84FB-340226A12B84Q38387683-C1580342-D0B0-4B78-9812-C95FC8B9C2F9Q39734398-00F27A7F-3412-486F-BF1B-6187B625B80CQ40099874-ABEDB1C7-0F0E-4798-A9AA-9C2C8D55246FQ44856520-6D6CA24F-8FA7-4570-BD19-02C23E05814BQ45272372-C4A55C57-C9DD-43E0-BFA6-C528651B224AQ45300561-76F9B9F3-F172-478B-93B7-BE9C74081641Q45301806-873C5A04-B82B-4FBB-A301-9A4628080FD3Q47553457-934CDEFE-551F-450A-B574-546CBC29E6E4Q47687627-6EB2B6FF-ADB9-40E3-BF2E-E7BDC15ECB2CQ48002756-309DEAF0-0DBB-451A-A9F4-42D13F10787E
P2860
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Medical costs and quality of l ...... essel coronary artery disease.
@ast
Medical costs and quality of l ...... essel coronary artery disease.
@en
Medical costs and quality of l ...... essel coronary artery disease.
@nl
type
label
Medical costs and quality of l ...... essel coronary artery disease.
@ast
Medical costs and quality of l ...... essel coronary artery disease.
@en
Medical costs and quality of l ...... essel coronary artery disease.
@nl
prefLabel
Medical costs and quality of l ...... essel coronary artery disease.
@ast
Medical costs and quality of l ...... essel coronary artery disease.
@en
Medical costs and quality of l ...... essel coronary artery disease.
@nl
P2093
P50
P921
P1433
P1476
Medical costs and quality of l ...... essel coronary artery disease.
@en
P2093
Derek B Boothroyd
Guy S Reeder
Kathryn A Melsop
Patrick L Whitlow
Robert D Wiens
Thomas J Ryan
William J Rogers
P304
P356
10.1161/01.CIR.0000143379.26342.5C
P407
P577
2004-09-27T00:00:00Z